Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Mina | - |
dc.contributor.author | Chai, Jin Choul | - |
dc.contributor.author | Choi, Hae In | - |
dc.contributor.author | Yoo, Eunyoung | - |
dc.contributor.author | Binas, Bert | - |
dc.contributor.author | Lee, Young Seek | - |
dc.contributor.author | Jung, Kyoung Hwa | - |
dc.contributor.author | Chai, Young Gyu | - |
dc.date.accessioned | 2023-07-05T05:44:41Z | - |
dc.date.available | 2023-07-05T05:44:41Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/113288 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poor prognosis. Emerging evidence suggests that epigenetic alterations play a crucial role in HCC, suggesting epigenetic inhibition as a promising therapeutic approach. Indeed, the bromodomain and extra-terminal (BET) inhibitors inhibit the proliferation and invasion of various cancers but still lack a strong mechanistic rationale. Here, we identified the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) in human HCC cell line HepG2 treated with the BET inhibitors, JQ1, OTX015, or ABBV-075. We analyzed the correlation between DEmRNAs and DElncRNAs in common for the three inhibitors based on their expression profiles and performed functional annotation pathway enrichment analysis. Most of these shared DEmRNAs and DElncRNAs, including some novel transcripts, were downregulated, indicating decreased proliferation/adhesion and increased apoptosis/inflammation. Our study suggests that BET proteins play a crucial role in regulating cancer progression-related genes and provide a valuable resource for novel putative biomarkers and therapeutic targets in HCC. © 2022 Baek et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited | - |
dc.format.extent | 21 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Public Library of Science | - |
dc.title | Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1371/journal.pone.0266966 | - |
dc.identifier.scopusid | 2-s2.0-85129220925 | - |
dc.identifier.bibliographicCitation | PLoS ONE, v.17, no.4 April, pp 1 - 21 | - |
dc.citation.title | PLoS ONE | - |
dc.citation.volume | 17 | - |
dc.citation.number | 4 April | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 21 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.url | https://www.scopus.com/record/display.uri?eid=2-s2.0-85129220925&origin=inward&txGid=8af512625de0d4ccd1231e1d28eab71b | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.